Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop.

Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

Trending weight loss drugs such as Ozempic and Wegovy may be highly effective at tackling obesity, but are they also carrying ...

I don’t eat before noon – but I worry it’s a bad idea - IN FOCUS: Depending on which research you read, breakfast is either ...

Todd Engel, a Maryland man, is suing Ozempic maker Novo Nordisk after allegedly going blind due to the drug, raising concerns ...

A new weight loss drug that's being trialled as a daily pill and could rival Ozempic has delivered some astonishing results.